indole and piperidine

indole has been researched along with piperidine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bartoszyk, GD; Böttcher, H; Greiner, HE; Heinrich, T; Seyfried, CA; Van Amsterdam, C1
Curillová, Z; Kutschy, P; McDonald, J; Mezencev, R; Mojzis, J; Pilátová, M; Salayová, A1
Anderskewitz, R; Dollinger, H; Grundl, MA; Kriegl, JM; Martyres, D; Rast, G; Schmid, B; Seither, P; Tautermann, CS1
Abe, H; Asawa, Y; Katsuragi, K; Makino, K; Nakamura, H; Nomura, M; Ogino, Y; Okazawa, M; Oyama, T; Sakamoto, Y; Sato, A; Shibasaki, Y; Takahashi, H; Tanuma, N; Tanuma, SI; Uchiumi, F; Yamazaki, H; Yoshimori, A1

Other Studies

4 other study(ies) available for indole and piperidine

ArticleYear
Indolebutylamines as selective 5-HT(1A) agonists.
    Journal of medicinal chemistry, 2004, Sep-09, Volume: 47, Issue:19

    Topics: Animals; Biological Availability; Butylamines; Hippocampus; Humans; Indoles; Inhibitory Concentration 50; Male; Molecular Structure; Oxindoles; Piperidines; Pyridines; Rats; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship; Substrate Specificity

2004
Anticancer properties of 2-piperidyl analogues of the natural indole phytoalexin 1-methoxyspirobrassinol.
    Chemotherapy, 2008, Volume: 54, Issue:5

    Topics: Antineoplastic Agents; Biological Products; Cell Line, Tumor; Cell Proliferation; Drug Evaluation, Preclinical; Humans; Indoles; Molecular Structure; Piperidines; Spiro Compounds; Structure-Activity Relationship

2008
Rodent selectivity of piperidine-4-yl-1H-indoles, a series of CC chemokine receptor-3 (CCR3) antagonists: insights from a receptor model.
    Bioorganic & medicinal chemistry letters, 2015, Jan-15, Volume: 25, Issue:2

    Topics: Animals; Humans; Indoles; Mice; Models, Molecular; Piperidines; Protein Structure, Secondary; Protein Structure, Tertiary; Rats; Receptors, CCR3; Species Specificity

2015
Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors.
    Molecules (Basel, Switzerland), 2020, Aug-10, Volume: 25, Issue:16

    Topics: Binding Sites; Catalytic Domain; Drug Design; Enzyme Inhibitors; Humans; Indoles; Kinetics; Molecular Docking Simulation; Nicotinamide Phosphoribosyltransferase; Piperazine; Piperidines

2020